Table 3

Subgroup analysis of myopic macular degeneration prevalence in the world population

SubgroupNo. of study/dataPooled prevalence and 95% CI (%)Heterogeneity, I2 (%)Q-valueP value
Sex
 Male111.9 (1.1 to 3.5)97.707436.158<0.001
 Female112.6 (1.6 to 4.3)97.872469.866
District
 Urban83.1 (1.8 to 5.2)98.752560.962<0.001
 Rural40.9 (0.5 to 1.4)91.22634.191
Region
 Asia111.9 (1.4 to 2.6)96.553290.110<0.001
 USA and Australia23.7 (0.4 to 26.5)99.507202.893
Age (years)
 40–4931.3 (1.0 to 1.7)01.190<0.001
 50–5972.0 (0.9 to 4.4)97.830276.453
 60–6983.0 (1.5 to 5.8)97.833323.001
 70+84.5 (2.6 to 7.8)96.338191.169
Axial length (mm)
 <2630.9 (0.1 to 7.1)95.79647.5710.001
 ≥2638.4 (2.1 to 28.2)96.69660.529
SE refraction levels (diopters)
 0.00 to −5.9940.5 (0.1 to 2.0)95.52767.0680.08
 ≤−6.00432.1 (16.9 to 52.2)93.25944.501
Conducted time
 1993–200671.3 (0.8 to 2.2)95.658138.200<0.001
 2007–201763.5 (1.9 to 6.3)99.052527.669
Grading system
 V51.6 (1.0 to 2.6)96.159104.132<0.001
 M44.7 (2.4 to 8.9)99.024307.388
  • M, International META-PM Classification; META-PM, meta analyses of pathologic myopia; SE, spherical equivalent; V, PM Classification by Vongphanit.